ASCIL Biopharm
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
ASCIL Biopharm - overview
Established
2012
Location
Barcelona, -, Spain
Primary Industry
Pharmaceuticals
About
Established in 2012 and based in Barcelona, Spain, ASCIL Biopharm develops pharmaceutical products and therapeutic treatments.
Primary Industry
Pharmaceuticals
Sub Industries
Pharmaceutical Research & Development
Website
www.ascil-biopharm.com
Verticals
HealthTech
Total Amount Raised
Subscriber access only
ASCIL Biopharm - timeline of key events
ASCIL Biopharm - financials
| Fiscal Year Ended | Dec 31, 2014 | Dec 31, 2015 | Dec 31, 2016 | Dec 31, 2017 | Dec 31, 2018 | Dec 31, 2019 | Dec 31, 2020 | Dec 31, 2021 | Dec 31, 2022 | Dec 31, 2023 | Dec 31, 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue (USD) | 1,775,651.5 | 2,082,933.9 | 2,045,993.8 | 1,735,833.1 | 1,351,093 | 1,670,715.8 | 2,125,000 | 2,455,900 | - | - | - |
| % Revenue Growth (YoY) | - | 17.3% | (1.8%) | (15.2%) | (22.2%) | 23.7% | 27.2% | 15.6% | - | - | - |
| EBITDA (USD) | 498,074.5 | 363,706.7 | 485,324.2 | (70,857.2) | (67,642.1) | (292,260.1) | (157,356.4) | (48,253.5) | - | - | - |
| Operating Income (USD) | 474,884.7 | 336,889.9 | 458,232.6 | (97,781.2) | (93,957.1) | (318,421.8) | (175,332.6) | (61,235.4) | - | - | - |
| Operating Margin | 26.7% | 16.2% | 22.4% | (5.6%) | (7.0%) | (19.1%) | (8.3%) | (2.5%) | - | - | - |
| % EBITDA Margin | 28.1% | 17.5% | 23.7% | (4.1%) | (5.0%) | (17.5%) | (7.4%) | (2.0%) | - | - | - |
| NET Income (USD) | 419,967.9 | 287,447.8 | 402,365.8 | (98,390.8) | (85,299.1) | (316,840.7) | (171,951.1) | (61,861.9) | - | - | - |
| % Net Margin | 23.7% | 13.8% | 19.7% | (5.7%) | (6.3%) | (19.0%) | (8.1%) | (2.5%) | - | - | - |
ASCIL Biopharm - employee data
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.